Quantcast
Last updated on April 16, 2014 at 14:14 EDT

Latest Breast cancer chemotherapy Stories

2008-05-28 03:00:08

By Galantino, Mary Lou Cannon, Nicole; Hoelker, Tiffany; Quinn, Lauren; Greene, Laurie ABSTRACT Introduction: Studies have revealed the benefits derived from yoga which includes improvements in quality of life (QOL) and decreased symptoms for women with breast cancer. Studies to date have not included specific measures of cognition with various interventions to improve QOL during survivorship. This case series tests the feasibility and use of yoga to determine perceived cognitive change and...

2006-07-05 16:08:17

By Gene Emery BOSTON (Reuters) - Stomach cancer patients who receive chemotherapy before and after surgery have significantly higher survival rates, according to a study published this week. "This is the first time we've been able to demonstrate that chemotherapy alone significantly improves outcome," David Cunningham, an oncologist at the Royal Marsden Hospital in England who led the study, told Reuters. Chemotherapy increased the five-year survival rate by 57 percent for a cancer...

2006-03-22 08:33:20

LONDON (Reuters) - Combining the drug Avastin with standard chemotherapy can keep breast cancer under control for longer in patients with advanced disease, scientists said on Wednesday. Avastin, which is made by Roche Holding AG and its majority-owned U.S. biotech arm Genentech Inc, blocks the growth of new blood vessels that are needed for the cancer to grow and spread, or metastasize, beyond the breast. When doctors combined the drug with the chemotherapy treatment Taxol in a study...

2005-07-15 12:21:01

NEW YORK (Reuters Health) - The combination of the anti-cancer drugs Herceptin and Taxotere appears to work better than Taxotere alone in women with advanced breast cancer that has spread beyond the breast, research shows. Moreover, there is little added toxicity when Herceptin is given. Herceptin (trastuzumab) is a monoclonal antibody, meaning that it binds to one specific protein, HER2, which helps regulate cell growth. Overexpression of HER2, a sign of more aggressive cancer, occurs in...

eda540e1f0caf01276d59fffa581ca9d
2005-06-03 07:20:00

Serious side effects can occur, but experts say benefits outweigh risks A combination of chemotherapy drugs can increase the five-year survival rate of women with node-positive breast cancer by about 7 percent, a new study finds. However, that gain doesn't come without a significant risk of serious side effects, researchers report in the June 2 issue of the New England Journal of Medicine. The drugs are docetaxel and doxorubicin, and this combination plus a third drug, cyclophosphamide, is...